Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Remarks:
Smith article: Range-finding toxicity data: list VI + Merck index
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Qualifier:
no guideline followed
Principles of method if other than guideline:
Single oral dose toxicity is estimated by the gastric intubation of groups of five non-fasted, Carworth-Wistar male rats, 4-5 weeks of age and 90-120 grams in weight. The dosages are arranged in a logarithmic seeries differing by a factor of two.
GLP compliance:
no
Test type:
other: single dose oral toxicity
Species:
rat
Strain:
Wistar
Sex:
male
Route of administration:
oral: gavage
Vehicle:
not specified
Sex:
male
Dose descriptor:
LD50
Effect level:
ca. 1 000 mg/kg bw
Based on:
test mat.
Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
H302 Acute tox 4 oral
Executive summary:

LD50 oral rat = 1000 mg/kg bw

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
LD50
Value:
1 000 mg/kg bw
Quality of whole database:
Klimisch 2

Acute toxicity: via inhalation route

Link to relevant study records
Reference
Endpoint:
acute toxicity: inhalation
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
other:
Justification for type of information:
As indicated in the attached article ( Clark), the typical use of indole is around 200 ppm to 0.01%.
Sometimes this goes up to 1% but above that the odour becomes unpleasant.
Fine fragrances are at most 15-30 % of the total, so at maximum, in an extreme case there would be 0.3 % indole in the end product.
More typically, for say a shampoo or functional product, the fragrance element is only up to 1% of the total product (often 0.2-0.5%) so the amount of indole is extremely low. In any event, the amounts we are talking about in the fragrances themselves are extremely small. The exposure can be negligible.
Endpoint conclusion
Quality of whole database:
vapour pressure 1.6 Pa ( 0.016 hPa) - which is more than 0.1 Pa - no waiving possible. Particle size is less than 100 Micrometer than waiving is possible R7a guidance. Need to measure particle size MMAD ( mass median aerodynamic diameter) with laser diffraction. For it need to spraying the material. IF MMAD is more than 30 Micrometer, than waiving is possible based silicone article. If no waiving possible than need to measure it, since a fragrance has an inhalation route. Since inhalation route is more relevant than dermal route for fragrances, that is why it is recommended to have tested. If dermal acue toxicity is more relevant than no need inhalation acute toxicity. Indole is a natural metabolite found in the human body, from metabolisim of amino-acids, so it is found in human exhaled air. We have no control of the particle size of the perfume user. Need to have a read-across quotation from Manuela.

Acute toxicity: via dermal route

Link to relevant study records
Reference
Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Qualifier:
no guideline followed
Principles of method if other than guideline:
Penetration of rabbit skin is estimated by a technique losely akin to the one-day cuff method of Draize and associates, using groups of four male albino New Zealand rabbits weighing 2.5-3.5 kg.
GLP compliance:
no
Species:
rabbit
Strain:
other: New Zealand albino
Sex:
male
Details on test animals or test system and environmental conditions:
4 rabbits were tested.
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
ca. 790 mg/kg bw
Based on:
test mat.
Interpretation of results:
Category 3 based on GHS criteria
Conclusions:
H311 Acute tox dermal cat 3
Executive summary:

LD 50 dermal rat = 790 mg/kg bw

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
LD50
Value:
790 mg/kg bw
Quality of whole database:
Klimisch 2

Additional information

Justification for classification or non-classification

H311 Acute tox 3 dermal

H302 Acute tox 4 oral